Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock

NCT01367743 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock

Interventions

DRUG: epinephrine perfusion
DRUG: norepinephrine perfusion

Sponsor

Central Hospital, Nancy, France